Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Pulmonary Arterial Hypertension Market
The Pulmonary Arterial Hypertension market size was valued at USD 5,659.18 million in 2018, increased to USD 7,999.27 million in 2024, and is anticipated to reach USD 12,502.58 million by 2032, at a CAGR of 5.34% during the forecast period.
-
Acitretin Market
The Acitretin Market size was valued at USD 34810 million in 2024 and is anticipated to reach USD 79644.6 million by 2032, at a CAGR of 10.9% during the forecast period (2024-2032).
-
SGLT2 Inhibitors Market
The Global SGLT2 Inhibitors Market size was valued at USD 12,900.00 million in 2018 to USD 16,972.96 million in 2024 and is anticipated to reach USD 30,693.09 million by 2032, at a CAGR of 7.72% during the forecast period.
-
South East Asia Umbilical Cord Blood Market
The South East Asia Umbilical Cord Blood Market size was valued at USD 180.00 million in 2018 to USD 315.69 million in 2024 and is anticipated to reach USD 1,087.29 million by 2032, at a CAGR of 16.79% during the forecast period.
-
Spheroids in Immuno-Oncology Market
The Global Spheroids in Immuno-Oncology Market size was valued at USD 380.00 million in 2018, reached USD 649.12 million in 2024, and is anticipated to reach USD 3,409.37 million by 2032, expanding at a CAGR of 23.16% during the forecast period.
-
Oral Antidiabetic Drugs Market
The Global Oral Antidiabetic Drugs (OADs) Market size was valued at USD 37,500.00 million in 2018 to USD 43,606.66 million in 2024 and is anticipated to reach USD 62,107.31 million by 2032, at a CAGR of 4.56% during the forecast period.
-
Insulin Biosimilars Market
The Global Insulin Biosimilars Market size was valued at USD 2,300.00 million in 2018 to USD 3,026.19 million in 2024 and is anticipated to reach USD 5,472.41 million by 2032, at a CAGR of 7.72% during the forecast period.
-
Gestational Diabetes Market
The Global Gestational Diabetes Market size was valued at USD 6,890.00 million in 2018 to USD 9,471.43 million in 2024 and is anticipated to reach USD 18,814.79 million by 2032, at a CAGR of 9.01% during the forecast period.
-
Dipeptidyl Peptidase‑4 (DPP‑4 ) Inhibitors Market
The Global Dipeptidyl Peptidase‑4 (DPP‑4 ) Inhibitors Market size was valued at USD 10,450.00 million in 2018 to USD 11,533.49 million in 2024 and is anticipated to reach USD 15,979.25 million by 2032, at a CAGR of 4.22% during the forecast period.
-
Diabetic Neuropathy Management Market
The Global Diabetic Neuropathy Management Market size was valued at USD 2,320.00 million in 2018 to USD 3,052.50 million in 2024 and is anticipated to reach USD 5,520.00 million by 2032, at a CAGR of 7.72% during the forecast period.
